nodes	percent_of_prediction	percent_of_DWPC	metapath
Glycopyrrolate—CHRM3—Carbachol—glaucoma	0.144	0.194	CbGbCtD
Glycopyrrolate—CHRM3—Pilocarpine—glaucoma	0.134	0.18	CbGbCtD
Glycopyrrolate—CHRM1—Carbachol—glaucoma	0.125	0.169	CbGbCtD
Glycopyrrolate—CHRM1—Pilocarpine—glaucoma	0.116	0.157	CbGbCtD
Glycopyrrolate—CHRM2—Carbachol—glaucoma	0.115	0.156	CbGbCtD
Glycopyrrolate—CHRM2—Pilocarpine—glaucoma	0.107	0.145	CbGbCtD
Glycopyrrolate—Headache—Latanoprost—glaucoma	0.000264	0.00105	CcSEcCtD
Glycopyrrolate—Skin disorder—Brinzolamide—glaucoma	0.000264	0.00104	CcSEcCtD
Glycopyrrolate—Confusional state—Pilocarpine—glaucoma	0.000263	0.00104	CcSEcCtD
Glycopyrrolate—Insomnia—Brimonidine—glaucoma	0.000262	0.00104	CcSEcCtD
Glycopyrrolate—Oedema—Pilocarpine—glaucoma	0.000261	0.00103	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Acetazolamide—glaucoma	0.00026	0.00103	CcSEcCtD
Glycopyrrolate—Fatigue—Acetazolamide—glaucoma	0.00026	0.00103	CcSEcCtD
Glycopyrrolate—Infection—Pilocarpine—glaucoma	0.00026	0.00103	CcSEcCtD
Glycopyrrolate—Nausea—Methazolamide—glaucoma	0.000259	0.00102	CcSEcCtD
Glycopyrrolate—Hypotension—Dorzolamide—glaucoma	0.000258	0.00102	CcSEcCtD
Glycopyrrolate—Somnolence—Brimonidine—glaucoma	0.000257	0.00102	CcSEcCtD
Glycopyrrolate—Mental disorder—Clonidine—glaucoma	0.000257	0.00102	CcSEcCtD
Glycopyrrolate—Hypotension—Travoprost—glaucoma	0.000257	0.00102	CcSEcCtD
Glycopyrrolate—Rhinitis—Betaxolol—glaucoma	0.000256	0.00101	CcSEcCtD
Glycopyrrolate—Erythema—Clonidine—glaucoma	0.000256	0.00101	CcSEcCtD
Glycopyrrolate—Tachycardia—Pilocarpine—glaucoma	0.000255	0.00101	CcSEcCtD
Glycopyrrolate—Dyspepsia—Brimonidine—glaucoma	0.000255	0.00101	CcSEcCtD
Glycopyrrolate—Hypoaesthesia—Betaxolol—glaucoma	0.000254	0.00101	CcSEcCtD
Glycopyrrolate—Hypotension—Brinzolamide—glaucoma	0.000254	0.001	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Pilocarpine—glaucoma	0.000253	0.000999	CcSEcCtD
Glycopyrrolate—Tension—Clonidine—glaucoma	0.000251	0.000992	CcSEcCtD
Glycopyrrolate—Insomnia—Dorzolamide—glaucoma	0.00025	0.000989	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Brimonidine—glaucoma	0.00025	0.000989	CcSEcCtD
Glycopyrrolate—Fatigue—Brimonidine—glaucoma	0.00025	0.000987	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Acetazolamide—glaucoma	0.000249	0.000983	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Apraclonidine—glaucoma	0.000248	0.000983	CcSEcCtD
Glycopyrrolate—Nervousness—Clonidine—glaucoma	0.000248	0.000982	CcSEcCtD
Glycopyrrolate—Pain—Brimonidine—glaucoma	0.000248	0.000979	CcSEcCtD
Glycopyrrolate—Insomnia—Brinzolamide—glaucoma	0.000246	0.000973	CcSEcCtD
Glycopyrrolate—Somnolence—Dorzolamide—glaucoma	0.000246	0.000972	CcSEcCtD
Glycopyrrolate—Hypotension—Pilocarpine—glaucoma	0.000244	0.000966	CcSEcCtD
Glycopyrrolate—Dysuria—Timolol—glaucoma	0.000244	0.000965	CcSEcCtD
Glycopyrrolate—Dyspepsia—Dorzolamide—glaucoma	0.000243	0.000963	CcSEcCtD
Glycopyrrolate—Upper respiratory tract infection—Timolol—glaucoma	0.000243	0.000959	CcSEcCtD
Glycopyrrolate—Dyspepsia—Travoprost—glaucoma	0.000242	0.000959	CcSEcCtD
Glycopyrrolate—Asthenia—Apraclonidine—glaucoma	0.000242	0.000957	CcSEcCtD
Glycopyrrolate—Somnolence—Brinzolamide—glaucoma	0.000242	0.000956	CcSEcCtD
Glycopyrrolate—Vision blurred—Clonidine—glaucoma	0.000241	0.000953	CcSEcCtD
Glycopyrrolate—Erectile dysfunction—Timolol—glaucoma	0.00024	0.000951	CcSEcCtD
Glycopyrrolate—Urticaria—Acetazolamide—glaucoma	0.00024	0.000948	CcSEcCtD
Glycopyrrolate—Dyspepsia—Brinzolamide—glaucoma	0.000239	0.000947	CcSEcCtD
Glycopyrrolate—Pruritus—Apraclonidine—glaucoma	0.000239	0.000944	CcSEcCtD
Glycopyrrolate—Body temperature increased—Acetazolamide—glaucoma	0.000238	0.000943	CcSEcCtD
Glycopyrrolate—Fatigue—Dorzolamide—glaucoma	0.000238	0.000943	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Travoprost—glaucoma	0.000238	0.00094	CcSEcCtD
Glycopyrrolate—Fatigue—Travoprost—glaucoma	0.000237	0.000939	CcSEcCtD
Glycopyrrolate—Cardiac disorder—Betaxolol—glaucoma	0.000237	0.000939	CcSEcCtD
Glycopyrrolate—Flushing—Betaxolol—glaucoma	0.000237	0.000939	CcSEcCtD
Glycopyrrolate—Pain—Dorzolamide—glaucoma	0.000236	0.000935	CcSEcCtD
Glycopyrrolate—Insomnia—Pilocarpine—glaucoma	0.000236	0.000935	CcSEcCtD
Glycopyrrolate—Pain—Travoprost—glaucoma	0.000235	0.000931	CcSEcCtD
Glycopyrrolate—Constipation—Travoprost—glaucoma	0.000235	0.000931	CcSEcCtD
Glycopyrrolate—Hyperglycaemia—Timolol—glaucoma	0.000235	0.000931	CcSEcCtD
Glycopyrrolate—Agitation—Clonidine—glaucoma	0.000235	0.000929	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000235	0.000928	CcSEcCtD
Glycopyrrolate—Asthenia—Bimatoprost—glaucoma	0.000235	0.000928	CcSEcCtD
Glycopyrrolate—Fatigue—Brinzolamide—glaucoma	0.000234	0.000927	CcSEcCtD
Glycopyrrolate—Pain—Brinzolamide—glaucoma	0.000232	0.00092	CcSEcCtD
Glycopyrrolate—Somnolence—Pilocarpine—glaucoma	0.000232	0.000919	CcSEcCtD
Glycopyrrolate—Pruritus—Bimatoprost—glaucoma	0.000231	0.000915	CcSEcCtD
Glycopyrrolate—Mediastinal disorder—Betaxolol—glaucoma	0.00023	0.000912	CcSEcCtD
Glycopyrrolate—Dyspepsia—Pilocarpine—glaucoma	0.00023	0.00091	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Dorzolamide—glaucoma	0.000228	0.000901	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Travoprost—glaucoma	0.000227	0.000897	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Dorzolamide—glaucoma	0.000226	0.000894	CcSEcCtD
Glycopyrrolate—Palpitations—Clonidine—glaucoma	0.000226	0.000894	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000226	0.000892	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Travoprost—glaucoma	0.000225	0.000891	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Brinzolamide—glaucoma	0.000224	0.000886	CcSEcCtD
Glycopyrrolate—Mental disorder—Betaxolol—glaucoma	0.000224	0.000886	CcSEcCtD
Glycopyrrolate—Constipation—Pilocarpine—glaucoma	0.000223	0.000884	CcSEcCtD
Glycopyrrolate—Pain—Pilocarpine—glaucoma	0.000223	0.000884	CcSEcCtD
Glycopyrrolate—Sweating—Timolol—glaucoma	0.000223	0.000882	CcSEcCtD
Glycopyrrolate—Dizziness—Apraclonidine—glaucoma	0.000223	0.000882	CcSEcCtD
Glycopyrrolate—Erythema—Betaxolol—glaucoma	0.000223	0.00088	CcSEcCtD
Glycopyrrolate—Malnutrition—Betaxolol—glaucoma	0.000223	0.00088	CcSEcCtD
Glycopyrrolate—Urticaria—Dorzolamide—glaucoma	0.00022	0.000869	CcSEcCtD
Glycopyrrolate—Epistaxis—Timolol—glaucoma	0.000219	0.000868	CcSEcCtD
Glycopyrrolate—Abdominal pain—Dorzolamide—glaucoma	0.000219	0.000865	CcSEcCtD
Glycopyrrolate—Body temperature increased—Dorzolamide—glaucoma	0.000219	0.000865	CcSEcCtD
Glycopyrrolate—Tension—Betaxolol—glaucoma	0.000218	0.000864	CcSEcCtD
Glycopyrrolate—Sinusitis—Timolol—glaucoma	0.000218	0.000864	CcSEcCtD
Glycopyrrolate—Dysgeusia—Betaxolol—glaucoma	0.000218	0.000862	CcSEcCtD
Glycopyrrolate—Abdominal pain—Travoprost—glaucoma	0.000218	0.000861	CcSEcCtD
Glycopyrrolate—Asthenia—Acetazolamide—glaucoma	0.000216	0.000856	CcSEcCtD
Glycopyrrolate—Dizziness—Bimatoprost—glaucoma	0.000216	0.000855	CcSEcCtD
Glycopyrrolate—Nervousness—Betaxolol—glaucoma	0.000216	0.000855	CcSEcCtD
Glycopyrrolate—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000216	0.000855	CcSEcCtD
Glycopyrrolate—Urticaria—Brinzolamide—glaucoma	0.000216	0.000854	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Pilocarpine—glaucoma	0.000215	0.000852	CcSEcCtD
Glycopyrrolate—Vomiting—Apraclonidine—glaucoma	0.000214	0.000848	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Pilocarpine—glaucoma	0.000214	0.000845	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Brimonidine—glaucoma	0.000213	0.000844	CcSEcCtD
Glycopyrrolate—Dry mouth—Clonidine—glaucoma	0.000213	0.000842	CcSEcCtD
Glycopyrrolate—Dermatitis—Apraclonidine—glaucoma	0.000212	0.00084	CcSEcCtD
Glycopyrrolate—Headache—Apraclonidine—glaucoma	0.000211	0.000836	CcSEcCtD
Glycopyrrolate—Confusional state—Clonidine—glaucoma	0.00021	0.000832	CcSEcCtD
Glycopyrrolate—Vision blurred—Betaxolol—glaucoma	0.00021	0.00083	CcSEcCtD
Glycopyrrolate—Rhinitis—Timolol—glaucoma	0.000209	0.000828	CcSEcCtD
Glycopyrrolate—Oedema—Clonidine—glaucoma	0.000209	0.000825	CcSEcCtD
Glycopyrrolate—Asthenia—Brimonidine—glaucoma	0.000208	0.000822	CcSEcCtD
Glycopyrrolate—Infection—Clonidine—glaucoma	0.000207	0.00082	CcSEcCtD
Glycopyrrolate—Abdominal pain—Pilocarpine—glaucoma	0.000207	0.000817	CcSEcCtD
Glycopyrrolate—Body temperature increased—Pilocarpine—glaucoma	0.000207	0.000817	CcSEcCtD
Glycopyrrolate—Rash—Bimatoprost—glaucoma	0.000206	0.000816	CcSEcCtD
Glycopyrrolate—Dermatitis—Bimatoprost—glaucoma	0.000206	0.000815	CcSEcCtD
Glycopyrrolate—Connective tissue disorder—Timolol—glaucoma	0.000205	0.000812	CcSEcCtD
Glycopyrrolate—Pruritus—Brimonidine—glaucoma	0.000205	0.00081	CcSEcCtD
Glycopyrrolate—Headache—Bimatoprost—glaucoma	0.000205	0.00081	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Clonidine—glaucoma	0.000205	0.000809	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Dorzolamide—glaucoma	0.000204	0.000806	CcSEcCtD
Glycopyrrolate—Tachycardia—Clonidine—glaucoma	0.000204	0.000806	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Travoprost—glaucoma	0.000203	0.000802	CcSEcCtD
Glycopyrrolate—Skin disorder—Clonidine—glaucoma	0.000203	0.000802	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Clonidine—glaucoma	0.000202	0.000798	CcSEcCtD
Glycopyrrolate—Nausea—Apraclonidine—glaucoma	0.0002	0.000792	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Brinzolamide—glaucoma	0.0002	0.000792	CcSEcCtD
Glycopyrrolate—Dizziness—Acetazolamide—glaucoma	0.000199	0.000789	CcSEcCtD
Glycopyrrolate—Asthenia—Dorzolamide—glaucoma	0.000198	0.000785	CcSEcCtD
Glycopyrrolate—Asthenia—Travoprost—glaucoma	0.000198	0.000781	CcSEcCtD
Glycopyrrolate—Palpitations—Betaxolol—glaucoma	0.000197	0.000778	CcSEcCtD
Glycopyrrolate—Pruritus—Dorzolamide—glaucoma	0.000196	0.000774	CcSEcCtD
Glycopyrrolate—Asthenia—Brinzolamide—glaucoma	0.000195	0.000772	CcSEcCtD
Glycopyrrolate—Hypotension—Clonidine—glaucoma	0.000195	0.000771	CcSEcCtD
Glycopyrrolate—Pruritus—Travoprost—glaucoma	0.000195	0.000771	CcSEcCtD
Glycopyrrolate—Nausea—Bimatoprost—glaucoma	0.000194	0.000768	CcSEcCtD
Glycopyrrolate—Cardiac disorder—Timolol—glaucoma	0.000194	0.000767	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Pilocarpine—glaucoma	0.000192	0.000761	CcSEcCtD
Glycopyrrolate—Pruritus—Brinzolamide—glaucoma	0.000192	0.000761	CcSEcCtD
Glycopyrrolate—Vomiting—Acetazolamide—glaucoma	0.000192	0.000759	CcSEcCtD
Glycopyrrolate—Dizziness—Brimonidine—glaucoma	0.000191	0.000757	CcSEcCtD
Glycopyrrolate—Headache—Acetazolamide—glaucoma	0.000189	0.000748	CcSEcCtD
Glycopyrrolate—Insomnia—Clonidine—glaucoma	0.000189	0.000747	CcSEcCtD
Glycopyrrolate—Mediastinal disorder—Timolol—glaucoma	0.000188	0.000745	CcSEcCtD
Glycopyrrolate—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000188	0.000744	CcSEcCtD
Glycopyrrolate—Asthenia—Pilocarpine—glaucoma	0.000187	0.000742	CcSEcCtD
Glycopyrrolate—Somnolence—Clonidine—glaucoma	0.000185	0.000734	CcSEcCtD
Glycopyrrolate—Dry mouth—Betaxolol—glaucoma	0.000185	0.000733	CcSEcCtD
Glycopyrrolate—Pruritus—Pilocarpine—glaucoma	0.000185	0.000731	CcSEcCtD
Glycopyrrolate—Confusional state—Betaxolol—glaucoma	0.000183	0.000725	CcSEcCtD
Glycopyrrolate—Mental disorder—Timolol—glaucoma	0.000183	0.000724	CcSEcCtD
Glycopyrrolate—Dizziness—Dorzolamide—glaucoma	0.000183	0.000723	CcSEcCtD
Glycopyrrolate—Rash—Brimonidine—glaucoma	0.000183	0.000722	CcSEcCtD
Glycopyrrolate—Dermatitis—Brimonidine—glaucoma	0.000182	0.000721	CcSEcCtD
Glycopyrrolate—Dizziness—Travoprost—glaucoma	0.000182	0.00072	CcSEcCtD
Glycopyrrolate—Erythema—Timolol—glaucoma	0.000182	0.000719	CcSEcCtD
Glycopyrrolate—Malnutrition—Timolol—glaucoma	0.000182	0.000719	CcSEcCtD
Glycopyrrolate—Oedema—Betaxolol—glaucoma	0.000182	0.000719	CcSEcCtD
Glycopyrrolate—Headache—Brimonidine—glaucoma	0.000181	0.000718	CcSEcCtD
Glycopyrrolate—Infection—Betaxolol—glaucoma	0.00018	0.000714	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Clonidine—glaucoma	0.00018	0.000713	CcSEcCtD
Glycopyrrolate—Fatigue—Clonidine—glaucoma	0.00018	0.000712	CcSEcCtD
Glycopyrrolate—Dizziness—Brinzolamide—glaucoma	0.00018	0.000711	CcSEcCtD
Glycopyrrolate—Nausea—Acetazolamide—glaucoma	0.000179	0.000709	CcSEcCtD
Glycopyrrolate—Tension—Timolol—glaucoma	0.000178	0.000706	CcSEcCtD
Glycopyrrolate—Pain—Clonidine—glaucoma	0.000178	0.000706	CcSEcCtD
Glycopyrrolate—Constipation—Clonidine—glaucoma	0.000178	0.000706	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Betaxolol—glaucoma	0.000178	0.000705	CcSEcCtD
Glycopyrrolate—Dysgeusia—Timolol—glaucoma	0.000178	0.000704	CcSEcCtD
Glycopyrrolate—Tachycardia—Betaxolol—glaucoma	0.000177	0.000701	CcSEcCtD
Glycopyrrolate—Nervousness—Timolol—glaucoma	0.000177	0.000699	CcSEcCtD
Glycopyrrolate—Skin disorder—Betaxolol—glaucoma	0.000176	0.000698	CcSEcCtD
Glycopyrrolate—Vomiting—Dorzolamide—glaucoma	0.000176	0.000695	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Betaxolol—glaucoma	0.000176	0.000695	CcSEcCtD
Glycopyrrolate—Rash—Dorzolamide—glaucoma	0.000174	0.00069	CcSEcCtD
Glycopyrrolate—Dermatitis—Dorzolamide—glaucoma	0.000174	0.000689	CcSEcCtD
Glycopyrrolate—Rash—Travoprost—glaucoma	0.000174	0.000687	CcSEcCtD
Glycopyrrolate—Dermatitis—Travoprost—glaucoma	0.000173	0.000686	CcSEcCtD
Glycopyrrolate—Headache—Dorzolamide—glaucoma	0.000173	0.000685	CcSEcCtD
Glycopyrrolate—Vomiting—Brinzolamide—glaucoma	0.000173	0.000684	CcSEcCtD
Glycopyrrolate—Dizziness—Pilocarpine—glaucoma	0.000173	0.000683	CcSEcCtD
Glycopyrrolate—Headache—Travoprost—glaucoma	0.000172	0.000682	CcSEcCtD
Glycopyrrolate—Nausea—Brimonidine—glaucoma	0.000172	0.00068	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Clonidine—glaucoma	0.000172	0.00068	CcSEcCtD
Glycopyrrolate—Rash—Brinzolamide—glaucoma	0.000171	0.000678	CcSEcCtD
Glycopyrrolate—Vision blurred—Timolol—glaucoma	0.000171	0.000678	CcSEcCtD
Glycopyrrolate—Dermatitis—Brinzolamide—glaucoma	0.000171	0.000677	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Clonidine—glaucoma	0.000171	0.000675	CcSEcCtD
Glycopyrrolate—Headache—Brinzolamide—glaucoma	0.00017	0.000674	CcSEcCtD
Glycopyrrolate—Hypotension—Betaxolol—glaucoma	0.00017	0.000671	CcSEcCtD
Glycopyrrolate—Vomiting—Pilocarpine—glaucoma	0.000166	0.000657	CcSEcCtD
Glycopyrrolate—Urticaria—Clonidine—glaucoma	0.000166	0.000656	CcSEcCtD
Glycopyrrolate—Body temperature increased—Clonidine—glaucoma	0.000165	0.000652	CcSEcCtD
Glycopyrrolate—Abdominal pain—Clonidine—glaucoma	0.000165	0.000652	CcSEcCtD
Glycopyrrolate—Rash—Pilocarpine—glaucoma	0.000165	0.000652	CcSEcCtD
Glycopyrrolate—Dermatitis—Pilocarpine—glaucoma	0.000165	0.000651	CcSEcCtD
Glycopyrrolate—Insomnia—Betaxolol—glaucoma	0.000164	0.00065	CcSEcCtD
Glycopyrrolate—Nausea—Dorzolamide—glaucoma	0.000164	0.00065	CcSEcCtD
Glycopyrrolate—Headache—Pilocarpine—glaucoma	0.000164	0.000647	CcSEcCtD
Glycopyrrolate—Nausea—Travoprost—glaucoma	0.000164	0.000647	CcSEcCtD
Glycopyrrolate—Nausea—Brinzolamide—glaucoma	0.000161	0.000639	CcSEcCtD
Glycopyrrolate—Palpitations—Timolol—glaucoma	0.000161	0.000636	CcSEcCtD
Glycopyrrolate—Dyspepsia—Betaxolol—glaucoma	0.00016	0.000633	CcSEcCtD
Glycopyrrolate—Hypertension—Timolol—glaucoma	0.000157	0.000621	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Betaxolol—glaucoma	0.000157	0.00062	CcSEcCtD
Glycopyrrolate—Fatigue—Betaxolol—glaucoma	0.000157	0.00062	CcSEcCtD
Glycopyrrolate—Constipation—Betaxolol—glaucoma	0.000155	0.000614	CcSEcCtD
Glycopyrrolate—Pain—Betaxolol—glaucoma	0.000155	0.000614	CcSEcCtD
Glycopyrrolate—Nausea—Pilocarpine—glaucoma	0.000155	0.000614	CcSEcCtD
Glycopyrrolate—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000154	0.000608	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Clonidine—glaucoma	0.000154	0.000608	CcSEcCtD
Glycopyrrolate—Dry mouth—Timolol—glaucoma	0.000151	0.000599	CcSEcCtD
Glycopyrrolate—Asthenia—Clonidine—glaucoma	0.00015	0.000592	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Betaxolol—glaucoma	0.00015	0.000592	CcSEcCtD
Glycopyrrolate—Confusional state—Timolol—glaucoma	0.00015	0.000592	CcSEcCtD
Glycopyrrolate—Anaphylactic shock—Timolol—glaucoma	0.000148	0.000587	CcSEcCtD
Glycopyrrolate—Oedema—Timolol—glaucoma	0.000148	0.000587	CcSEcCtD
Glycopyrrolate—Pruritus—Clonidine—glaucoma	0.000148	0.000584	CcSEcCtD
Glycopyrrolate—Infection—Timolol—glaucoma	0.000147	0.000583	CcSEcCtD
Glycopyrrolate—Nervous system disorder—Timolol—glaucoma	0.000146	0.000576	CcSEcCtD
Glycopyrrolate—Urticaria—Betaxolol—glaucoma	0.000144	0.000571	CcSEcCtD
Glycopyrrolate—Skin disorder—Timolol—glaucoma	0.000144	0.00057	CcSEcCtD
Glycopyrrolate—Body temperature increased—Betaxolol—glaucoma	0.000144	0.000568	CcSEcCtD
Glycopyrrolate—Hyperhidrosis—Timolol—glaucoma	0.000143	0.000567	CcSEcCtD
Glycopyrrolate—Hypotension—Timolol—glaucoma	0.000139	0.000549	CcSEcCtD
Glycopyrrolate—Dizziness—Clonidine—glaucoma	0.000138	0.000546	CcSEcCtD
Glycopyrrolate—Insomnia—Timolol—glaucoma	0.000134	0.000531	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Betaxolol—glaucoma	0.000134	0.000529	CcSEcCtD
Glycopyrrolate—Vomiting—Clonidine—glaucoma	0.000133	0.000525	CcSEcCtD
Glycopyrrolate—Somnolence—Timolol—glaucoma	0.000132	0.000522	CcSEcCtD
Glycopyrrolate—Rash—Clonidine—glaucoma	0.000132	0.00052	CcSEcCtD
Glycopyrrolate—Dermatitis—Clonidine—glaucoma	0.000131	0.00052	CcSEcCtD
Glycopyrrolate—Headache—Clonidine—glaucoma	0.000131	0.000517	CcSEcCtD
Glycopyrrolate—Dyspepsia—Timolol—glaucoma	0.000131	0.000517	CcSEcCtD
Glycopyrrolate—Asthenia—Betaxolol—glaucoma	0.00013	0.000516	CcSEcCtD
Glycopyrrolate—Pruritus—Betaxolol—glaucoma	0.000129	0.000508	CcSEcCtD
Glycopyrrolate—Gastrointestinal disorder—Timolol—glaucoma	0.000128	0.000507	CcSEcCtD
Glycopyrrolate—Fatigue—Timolol—glaucoma	0.000128	0.000506	CcSEcCtD
Glycopyrrolate—Pain—Timolol—glaucoma	0.000127	0.000502	CcSEcCtD
Glycopyrrolate—Nausea—Clonidine—glaucoma	0.000124	0.00049	CcSEcCtD
Glycopyrrolate—Feeling abnormal—Timolol—glaucoma	0.000122	0.000484	CcSEcCtD
Glycopyrrolate—Gastrointestinal pain—Timolol—glaucoma	0.000121	0.00048	CcSEcCtD
Glycopyrrolate—Dizziness—Betaxolol—glaucoma	0.00012	0.000475	CcSEcCtD
Glycopyrrolate—Urticaria—Timolol—glaucoma	0.000118	0.000466	CcSEcCtD
Glycopyrrolate—Abdominal pain—Timolol—glaucoma	0.000117	0.000464	CcSEcCtD
Glycopyrrolate—Body temperature increased—Timolol—glaucoma	0.000117	0.000464	CcSEcCtD
Glycopyrrolate—Vomiting—Betaxolol—glaucoma	0.000115	0.000457	CcSEcCtD
Glycopyrrolate—Rash—Betaxolol—glaucoma	0.000115	0.000453	CcSEcCtD
Glycopyrrolate—Dermatitis—Betaxolol—glaucoma	0.000114	0.000453	CcSEcCtD
Glycopyrrolate—Headache—Betaxolol—glaucoma	0.000114	0.00045	CcSEcCtD
Glycopyrrolate—Hypersensitivity—Timolol—glaucoma	0.000109	0.000433	CcSEcCtD
Glycopyrrolate—Nausea—Betaxolol—glaucoma	0.000108	0.000427	CcSEcCtD
Glycopyrrolate—Asthenia—Timolol—glaucoma	0.000106	0.000421	CcSEcCtD
Glycopyrrolate—Pruritus—Timolol—glaucoma	0.000105	0.000415	CcSEcCtD
Glycopyrrolate—Dizziness—Timolol—glaucoma	9.81e-05	0.000388	CcSEcCtD
Glycopyrrolate—Vomiting—Timolol—glaucoma	9.43e-05	0.000373	CcSEcCtD
Glycopyrrolate—Rash—Timolol—glaucoma	9.36e-05	0.00037	CcSEcCtD
Glycopyrrolate—Dermatitis—Timolol—glaucoma	9.35e-05	0.00037	CcSEcCtD
Glycopyrrolate—Headache—Timolol—glaucoma	9.3e-05	0.000368	CcSEcCtD
Glycopyrrolate—Nausea—Timolol—glaucoma	8.81e-05	0.000349	CcSEcCtD
Glycopyrrolate—CHRM2—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	5.45e-05	0.00876	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR ligand binding—OPN4—glaucoma	5.34e-05	0.00859	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR ligand binding—OPN4—glaucoma	5.11e-05	0.00823	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	4.97e-05	0.00799	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	4.95e-05	0.00797	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	4.9e-05	0.00789	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR ligand binding—PTGFR—glaucoma	4.81e-05	0.00773	CbGpPWpGaD
Glycopyrrolate—CHRM1—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	4.73e-05	0.00761	CbGpPWpGaD
Glycopyrrolate—CHRM2—SIDS Susceptibility Pathways—HDAC9—glaucoma	4.73e-05	0.0076	CbGpPWpGaD
Glycopyrrolate—CHRM3—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	4.71e-05	0.00758	CbGpPWpGaD
Glycopyrrolate—CHRM2—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	4.67e-05	0.00751	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR ligand binding—PTGFR—glaucoma	4.6e-05	0.00741	CbGpPWpGaD
Glycopyrrolate—CHRM1—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	4.26e-05	0.00685	CbGpPWpGaD
Glycopyrrolate—CHRM3—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	4.24e-05	0.00683	CbGpPWpGaD
Glycopyrrolate—CHRM2—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	4.2e-05	0.00676	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR ligand binding—OPN4—glaucoma	3.6e-05	0.00579	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR ligand binding—OPN4—glaucoma	3.59e-05	0.00577	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR ligand binding—OPN4—glaucoma	3.55e-05	0.00572	CbGpPWpGaD
Glycopyrrolate—CHRM2—SIDS Susceptibility Pathways—NTRK2—glaucoma	3.38e-05	0.00544	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR ligand binding—PTGFR—glaucoma	3.24e-05	0.00521	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR ligand binding—PTGFR—glaucoma	3.23e-05	0.0052	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR ligand binding—PTGFR—glaucoma	3.2e-05	0.00515	CbGpPWpGaD
Glycopyrrolate—CHRM5—G alpha (q) signalling events—EDN1—glaucoma	3.03e-05	0.00488	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR downstream signaling—OPN4—glaucoma	3.02e-05	0.00485	CbGpPWpGaD
Glycopyrrolate—CHRM4—Regulation of Actin Cytoskeleton—FN1—glaucoma	2.91e-05	0.00469	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR downstream signaling—OPN4—glaucoma	2.89e-05	0.00465	CbGpPWpGaD
Glycopyrrolate—CHRM5—Regulation of Actin Cytoskeleton—FN1—glaucoma	2.79e-05	0.00449	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—OPN4—glaucoma	2.74e-05	0.00441	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR downstream signaling—PTGFR—glaucoma	2.72e-05	0.00437	CbGpPWpGaD
Glycopyrrolate—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—glaucoma	2.71e-05	0.00437	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—OPN4—glaucoma	2.62e-05	0.00422	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR downstream signaling—PTGFR—glaucoma	2.6e-05	0.00419	CbGpPWpGaD
Glycopyrrolate—CHRM2—SIDS Susceptibility Pathways—BDNF—glaucoma	2.52e-05	0.00406	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—CA5A—glaucoma	2.48e-05	0.00398	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—NARFL—glaucoma	2.48e-05	0.00398	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—PTGFR—glaucoma	2.47e-05	0.00397	CbGpPWpGaD
Glycopyrrolate—CHRM2—SIDS Susceptibility Pathways—IL1A—glaucoma	2.42e-05	0.0039	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR ligand binding—SMO—glaucoma	2.42e-05	0.0039	CbGpPWpGaD
Glycopyrrolate—CHRM1—Circadian rythm related genes—NGFR—glaucoma	2.4e-05	0.00386	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—PTGFR—glaucoma	2.36e-05	0.0038	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—LRP12—glaucoma	2.33e-05	0.00376	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR ligand binding—SMO—glaucoma	2.32e-05	0.00373	CbGpPWpGaD
Glycopyrrolate—CHRM4—G alpha (i) signalling events—C3—glaucoma	2.31e-05	0.00371	CbGpPWpGaD
Glycopyrrolate—CHRM1—Circadian rythm related genes—NTRK1—glaucoma	2.28e-05	0.00367	CbGpPWpGaD
Glycopyrrolate—CHRM2—SIDS Susceptibility Pathways—NGF—glaucoma	2.24e-05	0.00361	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—LRP12—glaucoma	2.24e-05	0.0036	CbGpPWpGaD
Glycopyrrolate—CHRM2—SIDS Susceptibility Pathways—NR3C1—glaucoma	2.23e-05	0.00359	CbGpPWpGaD
Glycopyrrolate—CHRM1—G alpha (q) signalling events—EDN1—glaucoma	2.14e-05	0.00344	CbGpPWpGaD
Glycopyrrolate—CHRM3—G alpha (q) signalling events—EDN1—glaucoma	2.13e-05	0.00343	CbGpPWpGaD
Glycopyrrolate—CHRM4—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	2.1e-05	0.00338	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—OPN4—glaucoma	2.03e-05	0.00327	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—OPN4—glaucoma	2.03e-05	0.00326	CbGpPWpGaD
Glycopyrrolate—CHRM5—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	2.01e-05	0.00323	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—OPN4—glaucoma	2.01e-05	0.00323	CbGpPWpGaD
Glycopyrrolate—CHRM1—Regulation of Actin Cytoskeleton—FN1—glaucoma	1.97e-05	0.00316	CbGpPWpGaD
Glycopyrrolate—CHRM3—Regulation of Actin Cytoskeleton—FN1—glaucoma	1.96e-05	0.00315	CbGpPWpGaD
Glycopyrrolate—CHRM2—Regulation of Actin Cytoskeleton—FN1—glaucoma	1.94e-05	0.00312	CbGpPWpGaD
Glycopyrrolate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—glaucoma	1.91e-05	0.00307	CbGpPWpGaD
Glycopyrrolate—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—glaucoma	1.9e-05	0.00306	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—OPN4—glaucoma	1.85e-05	0.00297	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—OPN4—glaucoma	1.84e-05	0.00296	CbGpPWpGaD
Glycopyrrolate—CHRM4—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	1.83e-05	0.00295	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—PTGFR—glaucoma	1.83e-05	0.00295	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—PTGFR—glaucoma	1.83e-05	0.00294	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—OPN4—glaucoma	1.82e-05	0.00293	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—PTGFR—glaucoma	1.81e-05	0.00291	CbGpPWpGaD
Glycopyrrolate—CHRM1—Circadian rythm related genes—FAS—glaucoma	1.79e-05	0.00288	CbGpPWpGaD
Glycopyrrolate—CHRM5—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	1.76e-05	0.00282	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—PTGFR—glaucoma	1.66e-05	0.00268	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—PTGFR—glaucoma	1.66e-05	0.00267	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—PTGFR—glaucoma	1.64e-05	0.00264	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR ligand binding—SMO—glaucoma	1.63e-05	0.00263	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR ligand binding—SMO—glaucoma	1.63e-05	0.00262	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—OPN4—glaucoma	1.62e-05	0.0026	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR ligand binding—SMO—glaucoma	1.61e-05	0.0026	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR ligand binding—EDN1—glaucoma	1.6e-05	0.00257	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—LRP12—glaucoma	1.57e-05	0.00253	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—LRP12—glaucoma	1.57e-05	0.00253	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—LRP12—glaucoma	1.55e-05	0.0025	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—OPN4—glaucoma	1.55e-05	0.00249	CbGpPWpGaD
Glycopyrrolate—CHRM2—G alpha (i) signalling events—C3—glaucoma	1.53e-05	0.00247	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR ligand binding—EDN1—glaucoma	1.53e-05	0.00246	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—HEYL—glaucoma	1.5e-05	0.00242	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—PTGFR—glaucoma	1.46e-05	0.00234	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—HEYL—glaucoma	1.44e-05	0.00232	CbGpPWpGaD
Glycopyrrolate—CHRM1—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	1.41e-05	0.00228	CbGpPWpGaD
Glycopyrrolate—CHRM3—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	1.41e-05	0.00227	CbGpPWpGaD
Glycopyrrolate—CHRM2—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	1.4e-05	0.00225	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR ligand binding—C3—glaucoma	1.4e-05	0.00225	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—PTGFR—glaucoma	1.4e-05	0.00225	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR ligand binding—C3—glaucoma	1.34e-05	0.00215	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—SMO—glaucoma	1.24e-05	0.002	CbGpPWpGaD
Glycopyrrolate—CHRM1—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	1.24e-05	0.00199	CbGpPWpGaD
Glycopyrrolate—CHRM3—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	1.23e-05	0.00198	CbGpPWpGaD
Glycopyrrolate—CHRM2—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	1.22e-05	0.00196	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—CA1—glaucoma	1.21e-05	0.00195	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—SMO—glaucoma	1.19e-05	0.00192	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—CTSA—glaucoma	1.17e-05	0.00188	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—RPTOR—glaucoma	1.14e-05	0.00183	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—CA2—glaucoma	1.11e-05	0.00178	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—NCK2—glaucoma	1.1e-05	0.00178	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—RPTOR—glaucoma	1.09e-05	0.00176	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—OPN4—glaucoma	1.09e-05	0.00176	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—OPN4—glaucoma	1.09e-05	0.00175	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR ligand binding—EDN1—glaucoma	1.08e-05	0.00173	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—OPN4—glaucoma	1.08e-05	0.00173	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR ligand binding—EDN1—glaucoma	1.07e-05	0.00173	CbGpPWpGaD
Glycopyrrolate—CHRM2—SIDS Susceptibility Pathways—VEGFA—glaucoma	1.07e-05	0.00172	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR ligand binding—EDN1—glaucoma	1.06e-05	0.00171	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—NCK2—glaucoma	1.06e-05	0.0017	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—HEYL—glaucoma	1.01e-05	0.00163	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—HEYL—glaucoma	1.01e-05	0.00163	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—HEYL—glaucoma	1e-05	0.00161	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—PTGFR—glaucoma	9.83e-06	0.00158	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—PTGFR—glaucoma	9.79e-06	0.00158	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—PTGFR—glaucoma	9.7e-06	0.00156	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR ligand binding—C3—glaucoma	9.41e-06	0.00151	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—HDAC9—glaucoma	9.39e-06	0.00151	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR ligand binding—C3—glaucoma	9.38e-06	0.00151	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR ligand binding—C3—glaucoma	9.29e-06	0.0015	CbGpPWpGaD
Glycopyrrolate—CHRM2—SIDS Susceptibility Pathways—TNF—glaucoma	9.17e-06	0.00148	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR downstream signaling—EDN1—glaucoma	9.03e-06	0.00145	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—HDAC9—glaucoma	8.99e-06	0.00145	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR downstream signaling—EDN1—glaucoma	8.65e-06	0.00139	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—SMO—glaucoma	8.39e-06	0.00135	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—SMO—glaucoma	8.36e-06	0.00135	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—SMO—glaucoma	8.28e-06	0.00133	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—EDN1—glaucoma	8.2e-06	0.00132	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR downstream signaling—C3—glaucoma	7.89e-06	0.00127	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—EDN1—glaucoma	7.85e-06	0.00126	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—TXN—glaucoma	7.79e-06	0.00125	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—RPTOR—glaucoma	7.69e-06	0.00124	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—RPTOR—glaucoma	7.66e-06	0.00123	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—RPTOR—glaucoma	7.59e-06	0.00122	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR downstream signaling—C3—glaucoma	7.55e-06	0.00122	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—NCK2—glaucoma	7.45e-06	0.0012	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—NCK2—glaucoma	7.42e-06	0.00119	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—NCK2—glaucoma	7.35e-06	0.00118	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—SMO—glaucoma	7.35e-06	0.00118	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—C3—glaucoma	7.16e-06	0.00115	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—SMO—glaucoma	7.04e-06	0.00113	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—C3—glaucoma	6.86e-06	0.0011	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—NTRK2—glaucoma	6.72e-06	0.00108	CbGpPWpGaD
Glycopyrrolate—CHRM1—Circadian rythm related genes—TP53—glaucoma	6.69e-06	0.00108	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—NTRK2—glaucoma	6.44e-06	0.00104	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—HDAC9—glaucoma	6.33e-06	0.00102	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—HDAC9—glaucoma	6.31e-06	0.00102	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—HDAC9—glaucoma	6.25e-06	0.00101	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—EDN1—glaucoma	6.09e-06	0.00098	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—EDN1—glaucoma	6.07e-06	0.000977	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—GSTT1—glaucoma	6.04e-06	0.000972	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—EDN1—glaucoma	6.01e-06	0.000967	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—NGFR—glaucoma	5.77e-06	0.000928	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—EDN1—glaucoma	5.53e-06	0.00089	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—NGFR—glaucoma	5.52e-06	0.000888	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—EDN1—glaucoma	5.51e-06	0.000887	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—NTRK1—glaucoma	5.48e-06	0.000881	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—EDN1—glaucoma	5.46e-06	0.000878	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—C3—glaucoma	5.32e-06	0.000856	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—C3—glaucoma	5.3e-06	0.000853	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—C3—glaucoma	5.25e-06	0.000845	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—NTRK1—glaucoma	5.25e-06	0.000844	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—CDKN2B—glaucoma	5.05e-06	0.000812	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—SMO—glaucoma	4.95e-06	0.000797	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—SMO—glaucoma	4.94e-06	0.000795	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—SMO—glaucoma	4.89e-06	0.000787	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—EDN1—glaucoma	4.84e-06	0.000779	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—CDKN2B—glaucoma	4.83e-06	0.000778	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—C3—glaucoma	4.83e-06	0.000777	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—C3—glaucoma	4.82e-06	0.000775	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—CYP1B1—glaucoma	4.81e-06	0.000775	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—ABCA1—glaucoma	4.81e-06	0.000775	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—C3—glaucoma	4.77e-06	0.000767	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—EDN1—glaucoma	4.64e-06	0.000746	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—NTRK2—glaucoma	4.53e-06	0.000729	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—NTRK2—glaucoma	4.52e-06	0.000727	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—NTRK2—glaucoma	4.47e-06	0.00072	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—NGF—glaucoma	4.45e-06	0.000716	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—NGF—glaucoma	4.26e-06	0.000686	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—C3—glaucoma	4.23e-06	0.000681	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—C3—glaucoma	4.05e-06	0.000652	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—APOE—glaucoma	3.94e-06	0.000634	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—CAV1—glaucoma	3.9e-06	0.000628	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—NGFR—glaucoma	3.89e-06	0.000626	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—NGFR—glaucoma	3.88e-06	0.000624	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—GSTM1—glaucoma	3.85e-06	0.000619	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—NGFR—glaucoma	3.84e-06	0.000618	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—APOE—glaucoma	3.77e-06	0.000607	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—CAV1—glaucoma	3.74e-06	0.000601	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—FN1—glaucoma	3.72e-06	0.000598	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—NTRK1—glaucoma	3.69e-06	0.000594	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—NTRK1—glaucoma	3.68e-06	0.000592	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—BAD—glaucoma	3.67e-06	0.000591	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—NTRK1—glaucoma	3.65e-06	0.000587	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—FN1—glaucoma	3.56e-06	0.000573	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—BAD—glaucoma	3.52e-06	0.000566	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CDKN2B—glaucoma	3.4e-06	0.000548	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—MTHFR—glaucoma	3.4e-06	0.000547	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CDKN2B—glaucoma	3.39e-06	0.000546	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CDKN2B—glaucoma	3.36e-06	0.000541	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—EDN1—glaucoma	3.27e-06	0.000526	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—EDN1—glaucoma	3.26e-06	0.000524	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—EDN1—glaucoma	3.22e-06	0.000519	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—APOE—glaucoma	3.17e-06	0.00051	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—CAV1—glaucoma	3.14e-06	0.000505	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—NGF—glaucoma	3e-06	0.000483	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—NGF—glaucoma	2.99e-06	0.000481	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—NGF—glaucoma	2.96e-06	0.000477	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—NOS3—glaucoma	2.95e-06	0.000475	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—C3—glaucoma	2.85e-06	0.000459	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—C3—glaucoma	2.84e-06	0.000458	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—NOS3—glaucoma	2.83e-06	0.000455	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—C3—glaucoma	2.82e-06	0.000453	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—APOE—glaucoma	2.66e-06	0.000427	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—APOE—glaucoma	2.65e-06	0.000426	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CAV1—glaucoma	2.63e-06	0.000424	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CAV1—glaucoma	2.62e-06	0.000422	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—APOE—glaucoma	2.62e-06	0.000422	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CAV1—glaucoma	2.6e-06	0.000418	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—CDKN1B—glaucoma	2.56e-06	0.000411	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—FN1—glaucoma	2.51e-06	0.000403	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—FN1—glaucoma	2.5e-06	0.000402	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—BAD—glaucoma	2.48e-06	0.000398	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—FN1—glaucoma	2.47e-06	0.000398	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—BAD—glaucoma	2.47e-06	0.000397	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—CDKN1B—glaucoma	2.45e-06	0.000394	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—BAD—glaucoma	2.44e-06	0.000393	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—NOS3—glaucoma	2.37e-06	0.000382	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—MMP9—glaucoma	2.37e-06	0.000381	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—MMP9—glaucoma	2.27e-06	0.000365	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—PTGS2—glaucoma	2.17e-06	0.000349	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—VEGFA—glaucoma	2.13e-06	0.000342	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—VEGFA—glaucoma	2.04e-06	0.000328	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—NOS3—glaucoma	1.99e-06	0.00032	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—NOS3—glaucoma	1.98e-06	0.000319	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—NOS3—glaucoma	1.96e-06	0.000316	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—CDKN1B—glaucoma	1.72e-06	0.000277	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—CDKN1B—glaucoma	1.72e-06	0.000277	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—CDKN1B—glaucoma	1.7e-06	0.000274	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—TP53—glaucoma	1.61e-06	0.000259	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—MMP9—glaucoma	1.6e-06	0.000257	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—MMP9—glaucoma	1.59e-06	0.000256	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—MMP9—glaucoma	1.58e-06	0.000254	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—TP53—glaucoma	1.54e-06	0.000248	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—VEGFA—glaucoma	1.43e-06	0.000231	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—VEGFA—glaucoma	1.43e-06	0.00023	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—VEGFA—glaucoma	1.42e-06	0.000228	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—TP53—glaucoma	1.08e-06	0.000174	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—TP53—glaucoma	1.08e-06	0.000174	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—TP53—glaucoma	1.07e-06	0.000172	CbGpPWpGaD
